CIK 0001401914 · Non-accelerated filer<br>Smaller reporting company
Dare Bioscience, Inc.
Sign in to watch- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 204139823
- Phone
- 858-926-7655
- Business address
- 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-26 | Arbuckle Stuart A Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2015-05-27 | BELOFF GREGG Interim CFO | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2015-04-07 | CVF, LLC 10% owner | Purchase | +333,333 | $6.00 | $2.0M | 2,592,577 |
| 2015-03-23 | GUIFFRE CHRISTOPHERD T Chief Executive Officer | Grant or award · Stock Option (right to buy) | +407,520 | 407,520 | ||
| 2015-02-05 | GUIFFRE CHRISTOPHERD T Chief Operating Officer | Grant or award · Stock Option (right to buy) | +75,000 | 317,457 | ||
| 2015-02-05 | Roberts Karen Lynn Sr VP Finance & Administrat | Grant or award · Stock Option (right to buy) | +43,000 | 163,774 | ||
| 2015-02-05 | Garmey Edward Graeme Sr. VP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +43,000 | 166,586 | ||
| 2014-10-29 | GUIFFRE CHRISTOPHERD T Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +50,300 | 242,457 | ||
| 2014-10-29 | FRIEDMAN PAUL A Director | Grant or award · Stock Option (right to buy) | +100,000 | 113,786 | ||
| 2014-10-29 | Parkinson David Ross Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-10-03 | Kelley Susan L. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-09-16 | Crane Alan L Director | Returned to the company · Stock Option (right to buy) | −35,765 | 0 | ||
| 2014-09-16 | Crane Alan L Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2014-07-17 | Roberts Karen Lynn Sr VP Finance & Administrat | Grant or award · Stock Option (right to buy) | +20,100 | 120,774 | ||
| 2014-06-24 | FETZER OLIVER President and CEO | Grant or award · Stock Option (right to buy) | +290,000 | 730,569 | ||
| 2014-06-24 | GUIFFRE CHRISTOPHERD T Sr. VP, Chief Business Officer | Grant or award · Stock Option (right to buy) | +50,300 | 192,158 | ||
| 2014-06-24 | Garmey Edward Graeme Sr. VP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,300 | 123,586 | ||
| 2014-06-24 | Roberts Karen Lynn Sr VP Finance & Administrat | Grant or award · Stock Option (right to buy) | +38,200 | 100,674 | ||
| 2014-05-16 | FETZER OLIVER President and CEO | Option exercise | +30,000 | $3.34 | $100K | 30,000 |
| 2014-05-16 | FETZER OLIVER President and CEO | Option exercise · Stock Option (right to buy) | −30,000 | 102,215 |
Page 11 of 18 · 344 trades